BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25742226)

  • 1. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
    Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
    Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
    Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
    J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
    Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy.
    Quarta CC; Obici L; Guidalotti PL; Pieroni M; Longhi S; Perlini S; Verga L; Merlini G; Rapezzi C
    Amyloid; 2013 Mar; 20(1):48-51. PubMed ID: 23231421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
    Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen visualization in both TTR and AL amyloidosis during
    Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
    Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
    Rossi P; Tessonnier L; Frances Y; Mundler O; Granel B
    Clin Nucl Med; 2012 Aug; 37(8):e209-10. PubMed ID: 22785530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
    Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
    Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
    Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
    J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
    Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis.
    Ungericht M; Groaz V; Messner M; Schuetz T; Brunelli L; Zaruba MM; Lener D; Stocker E; Bauer A; Kroiss AS; Mayr A; Röcken C; Poelzl G
    Amyloid; 2024 Mar; 31(1):22-31. PubMed ID: 37530216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not All Heart Uptakes on 99mTc-DPD Scintigraphy Are Amyloidosis: Chloroquine-Induced Cardiomyopathy.
    Wakfie-Corieh CG; Ramos López N; Saiz-Pardo Sanz M; Pérez Castejón MJ; Vilacosta I
    Clin Nucl Med; 2021 Apr; 46(4):e188-e189. PubMed ID: 33208614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-phase myocardial uptake intensity of
    Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
    J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimized imaging protocol for [
    Schatka I; Bingel A; Schau F; Bluemel S; Messroghli DR; Frumkin D; Knebel F; Diekmann SM; Elsanhoury A; Tschöpe C; Hahn K; Amthauer H; Rogasch JMM; Wetz C
    J Nucl Cardiol; 2021 Dec; 28(6):2483-2496. PubMed ID: 34331215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
    Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
    Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of
    Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
    Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial uptake of
    de Miguel C; Llorente L; de Haro-Del Moral FJ; García-Pavía P; González-López E; Segovia J; Krsnik I
    Amyloid; 2017 Mar; 24(sup1):48-49. PubMed ID: 28434306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.